{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:27:21Z","timestamp":1793618841422,"version":"4.5.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ebiom.2026.106528","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:59:41Z","timestamp":1792760381000},"page":"106528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9352-2826","authenticated-orcid":false,"given":"L\u0151rinc","family":"Ulmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2861-2573","authenticated-orcid":false,"given":"Mahmoud","family":"Obeidat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6978-4526","authenticated-orcid":false,"given":"Stefania","family":"Bunduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szil\u00e1rd","family":"V\u00e1ncsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4553-647X","authenticated-orcid":false,"given":"Bogl\u00e1rka Lilla","family":"Szentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Baksay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Doh\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1kos","family":"Sz\u00fccs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2026.106528_bib1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/SLA.0000000000004147","article-title":"Actual five-year survival after upfront resection for pancreatic ductal adenocarcinoma: who beats the odds?","volume":"275","author":"Strobel","year":"2022","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4251\/wjgo.v12.i2.173","article-title":"Pancreatic ductal adenocarcinoma: treatment hurdles, tumor microenvironment and immunotherapy","volume":"12","author":"Sarantis","year":"2020","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S2468-1253(22)00348-X","article-title":"Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial","volume":"8","author":"Ghaneh","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9124128","article-title":"Molecular and metabolic subtypes correspondence for pancreatic ductal adenocarcinoma classification","volume":"9","author":"Espiau-Romera","year":"2020","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106528_bib6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/2767-9764.CRC-22-0190","article-title":"Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: a systematic review and meta-analysis","volume":"2","author":"Kane","year":"2022","journal-title":"Cancer Res Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbrc.2018.03.107","article-title":"Detection and proteomic characterization of extracellular vesicles in human pancreatic juice","volume":"499","author":"Osteikoetxea","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ebiom.2026.106528_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.trsl.2022.01.001","article-title":"Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma-a systematic review and meta-analysis","volume":"244","author":"Bunduc","year":"2022","journal-title":"Transl Res"},{"key":"10.1016\/j.ebiom.2026.106528_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103548","article-title":"Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: a systematic review and meta-analysis","volume":"169","author":"Bunduc","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.70019","article-title":"Subtype-associated complexity and prognostic significance of the NLRP3 inflammasome landscape in pancreatic neoplasms","volume":"11","author":"Nemeth","year":"2025","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.ebiom.2026.106528_bib11","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3389\/fonc.2020.01466","article-title":"Prognostic biomarkers for pancreatic ductal adenocarcinoma: an umbrella review","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47129-1","article-title":"MiR-200b categorizes patients into pancreas cystic lesion subgroups with different malignant potential","volume":"13","author":"Benke","year":"2023","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081713","article-title":"Using microRNAs networks to understand pancreatic Cancer-A literature review","volume":"12","author":"Przybyszewski","year":"2024","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib14","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1007\/s11010-021-04233-y","article-title":"MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer","volume":"476","author":"Xia","year":"2021","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10555-023-10127-w","article-title":"Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma","volume":"42","author":"Vahabi","year":"2023","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106528_bib16","doi-asserted-by":"crossref","first-page":"9380","DOI":"10.18632\/aging.103214","article-title":"Prognostic value of microRNAs in pancreatic cancer: a meta-analysis","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ebiom.2026.106528_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12957-016-0842-4","article-title":"Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis","volume":"14","author":"Hu","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ebiom.2026.106528_bib18","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib19","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1093\/pubmed\/fdac036","article-title":"Strengthening systematic reviews in public health: guidance in the Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition","volume":"44","author":"Cumpston","year":"2022","journal-title":"J Public Health (Oxf)"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","article-title":"PROSPERO: an international register of systematic review protocols","volume":"38","author":"Schiavo","year":"2019","journal-title":"Med Ref Serv Q"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib21","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1038\/s41591-024-03315-w","article-title":"Systems education can train the next generation of scientists and clinicians","volume":"30","author":"Hegyi","year":"2024","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106528_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051532","article-title":"Academia Europaea position paper on translational medicine: the cycle model for translating scientific results into community benefits","volume":"9","author":"Hegyi","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12874-017-0468-4","article-title":"What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"10.1016\/j.ebiom.2026.106528_bib25","author":"Rohatgi"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"issue":"7109","key":"10.1016\/j.ebiom.2026.106528_bib29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2026.106528_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106528_bib31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/rssc.12440","article-title":"Sensitivity analysis for publication bias in meta-analyses","volume":"69","author":"Mathur","year":"2020","journal-title":"J R Stat Soc Ser C Appl Stat"},{"key":"10.1016\/j.ebiom.2026.106528_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.ebiom.2026.106528_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ebiom.2026.106528_bib34","series-title":"Doing Meta-Analysis with R","author":"Mathias Harrer","year":"2021"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib35","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jrsm.1260","article-title":"Introduction, comparison, and validation of Meta-Essentials: a free and simple tool for meta-analysis","volume":"8","author":"Suurmond","year":"2017","journal-title":"Res Synth Methods"},{"issue":"15","key":"10.1016\/j.ebiom.2026.106528_bib37","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/sim.6111","article-title":"Meta-analysis of single-arm survival studies: a distribution-free approach for estimating summary survival curves with random effects","volume":"33","author":"Combescure","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.ebiom.2026.106528_bib38","series-title":"A Language and Environment for Statistical Computing","author":"Team","year":"2024"},{"key":"10.1016\/j.ebiom.2026.106528_bib39","series-title":"Meta-Analysis with R","author":"Guido Schwarzer","year":"2015"},{"issue":"D1","key":"10.1016\/j.ebiom.2026.106528_bib40","doi-asserted-by":"crossref","first-page":"D304","DOI":"10.1093\/nar\/gkad1071","article-title":"TarBase-v9.0 extends experimentally supported miRNA-gene interactions to cell-types and virally encoded miRNAs","volume":"52","author":"Skoufos","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinformatics"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106528_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.ebiom.2026.106528_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jclinepi.2019.12.023","article-title":"GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks","volume":"121","author":"Foroutan","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ebiom.2026.106528_bib44","series-title":"GRADEpro GDT: GRADEpro Guideline Development Tool","year":"2026"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/biostatistics\/kxq046","article-title":"Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis","volume":"12","author":"Rucker","year":"2011","journal-title":"Biostatistics"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3892\/ijo.2014.2743","article-title":"Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer","volume":"46","author":"Abue","year":"2015","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib48","first-page":"28","article-title":"Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer","volume":"3","author":"Ali","year":"2010","journal-title":"Am J Transl Res"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4172\/1948-5956.1000372","article-title":"Differential expression of MicroRNAs in tissues and plasma Co-exists as a biomarker for pancreatic cancer","volume":"7","author":"Ali","year":"2015","journal-title":"J Cancer Sci Ther"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib50","first-page":"5668","article-title":"Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter study of 686 patients","volume":"12","author":"Ali","year":"2022","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12253-018-0490-9","article-title":"Comparison of native aspirates and cytological smears obtained by EUS-guided biopsies for effective DNA\/RNA marker testing in pancreatic cancer","volume":"26","author":"Benesova","year":"2020","journal-title":"Pathol Oncol Res"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106528_bib52","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","article-title":"MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis","volume":"297","author":"Bloomston","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12859-019-2974-3","article-title":"miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer","volume":"20","author":"Borgmastars","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ebiom.2026.106528_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40364-017-0087-6","article-title":"Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers","volume":"5","author":"Calatayud","year":"2017","journal-title":"Biomark Res"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12032-014-0225-z","article-title":"Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer","volume":"31","author":"Chen","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.ebiom.2026.106528_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818824314","article-title":"MicroRNA-132 plays an independent prognostic role in pancreatic ductal adenocarcinoma and acts as a tumor suppressor","volume":"18","author":"Chen","year":"2019","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib57","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.3892\/ol.2017.6819","article-title":"Abnormal alterations of miR-1 and miR-214 are associated with clinicopathological features and prognosis of patients with PDAC","volume":"14","author":"Cheng","year":"2017","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12672-026-04389-3","article-title":"miR-4787-3p and miR-581 as predictive biomarkers for fibrosis and prognosis in pancreatic cancer","volume":"17","author":"Chen","year":"2026","journal-title":"Discov Oncol"},{"key":"10.1016\/j.ebiom.2026.106528_bib59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13148-015-0166-1","article-title":"MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II","volume":"7","author":"Dhayat","year":"2015","journal-title":"Clin Epigenetics"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106528_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090328","article-title":"Clinical impact of epithelial-to-mesenchymal transition regulating MicroRNAs in pancreatic ductal adenocarcinoma","volume":"10","author":"Dhayat","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib61","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11605-008-0584-x","article-title":"MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival","volume":"12","author":"Dillhoff","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081856","article-title":"Dysregulation of miRNAs targeting the IGF-1R pathway in pancreatic ductal adenocarcinoma","volume":"10","author":"Dobre","year":"2021","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib63","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jso.23750","article-title":"Stromal microRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer","volume":"110","author":"Donahue","year":"2014","journal-title":"J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106528_bib64","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/MPA.0000000000000640","article-title":"miR-216b targets FGFR1 and confers sensitivity to radiotherapy in pancreatic ductal adenocarcinoma patients without EGFR or KRAS mutation","volume":"45","author":"Egeli","year":"2016","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106528_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061693","article-title":"Tumor-suppressive miR-192-5p has prognostic value in pancreatic ductal adenocarcinoma","volume":"12","author":"Flammang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib66","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.gastro.2013.10.010","article-title":"MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression","volume":"146","author":"Frampton","year":"2014","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106528_bib67","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1245\/s10434-025-17540-1","article-title":"Cancer cell-derived exosomal miR-519a\/522-5p promotes pancreatic cancer progression by enhancing warburg effect","volume":"32","author":"Feng","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082440","article-title":"Identification and validation of circulating micrornas as prognostic biomarkers in pancreatic ductal adenocarcinoma patients undergoing surgical resection","volume":"9","author":"Gablo","year":"2020","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049145","article-title":"High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer","volume":"7","author":"Giovannetti","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13402-017-0315-y","article-title":"Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis","volume":"40","author":"Giulietti","year":"2017","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.ebiom.2026.106528_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.827259","article-title":"Establishment of a 4-miRNA prognostic model for risk stratification of patients with pancreatic adenocarcinoma","volume":"12","author":"Gong","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib72","first-page":"401","article-title":"Diagnostic and prognostic performance of MicroRNA-25, carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 in pancreatic ductal adenocarcinoma","volume":"48","author":"Gong","year":"2023","journal-title":"Iran J Med Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib73","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12885-018-4006-5","article-title":"An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker","volume":"18","author":"Goto","year":"2018","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106528_bib74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.21037\/atm.2020.03.53","article-title":"Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4(+) T cells","volume":"8","author":"Gu","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ebiom.2026.106528_bib75","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.omtn.2019.11.010","article-title":"Functional significance and therapeutic potential of miR-15a mimic in pancreatic ductal adenocarcinoma","volume":"19","author":"Guo","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106528_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.520","article-title":"Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis","volume":"11","author":"Guo","year":"2021","journal-title":"Clin Transl Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib77","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.pan.2023.10.019","article-title":"Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma","volume":"23","author":"Harada","year":"2023","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib78","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1245\/s10434-020-09440-3","article-title":"MicroRNA-593-3p expression in peritoneal lavage fluid as a prognostic marker for pancreatic cancer patients undergoing staging laparoscopy","volume":"28","author":"Hata","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib79","article-title":"LncRNA LINC02381\/miR-133b axis promotes tumorigenesis and predicts survival in pancreatic cancer","volume":"16","author":"He","year":"2025","journal-title":"Discov Oncol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106528_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70501","article-title":"CircHPCAL1 promotes the progression of pancreatic cancer via the regulation of STEAP2","volume":"15","author":"He","year":"2025","journal-title":"Clin Transl Med"},{"issue":"20","key":"10.1016\/j.ebiom.2026.106528_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015193","article-title":"Circulating miRNAs as noninvasive biomarkers for PDAC diagnosis and prognosis in Mexico","volume":"24","author":"Alvarez-Hilario","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22950-2","article-title":"miR-4653-3p overexpression is associated with a poor prognosis of pancreatic ductal adenocarcinoma via HIPK2 downregulation","volume":"12","author":"Hirabayashi","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib83","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1038\/s41598-017-04191-w","article-title":"miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer","volume":"7","author":"Hiramoto","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/CBM-170231","article-title":"Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer","volume":"20","author":"Hua","year":"2017","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.ebiom.2026.106528_bib85","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3389\/fonc.2019.01499","article-title":"MiR-24-3p inhibits the progression of pancreatic ductal adenocarcinoma through LAMB3 downregulation","volume":"9","author":"Huang","year":"2019","journal-title":"Front Oncol"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106528_bib86","first-page":"4638","article-title":"Evaluation of miR-429 as a novel serum biomarker for pancreatic ductal adenocarcinoma and analysis its tumor suppressor function and target genes","volume":"26","author":"Huang","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib87","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1038\/s41598-024-82369-9","article-title":"Serum microRNA-24-based nomogram predicts prognosis for patients with resected pancreatic cancer","volume":"15","author":"Huang","year":"2025","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106528_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010630","article-title":"Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer","volume":"5","author":"Hwang","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib89","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1245\/s10434-010-1188-8","article-title":"MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma","volume":"17","author":"Ikenaga","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib90","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1158\/1078-0432.CCR-11-0679","article-title":"MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma","volume":"18","author":"Jamieson","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib91","first-page":"501","article-title":"Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis","volume":"67","author":"Jia","year":"2020","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib92","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2023.2216756","article-title":"Expression of miR-425-5p in pancreatic carcinoma and its correlation with tumor immune microenvironment","volume":"36","author":"Jian","year":"2023","journal-title":"J Invest Surg"},{"issue":"2 Pt B","key":"10.1016\/j.ebiom.2026.106528_bib93","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.canlet.2014.11.007","article-title":"MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer","volume":"356","author":"Jiang","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ebiom.2026.106528_bib94","article-title":"Low serum miR-607 level as a potential diagnostic and prognostic biomarker in patients of pancreatic ductal adenocarcinoma: a preliminary study","volume":"2021","author":"Jiang","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2026.106528_bib95","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.2147\/OTT.S249662","article-title":"miR-934 as a prognostic marker facilitates cell proliferation and migration of pancreatic tumor by targeting PROX1","volume":"13","author":"Jin","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111621","article-title":"Are ENT1\/ENT1, NOTCH3, and miR-21 reliable prognostic biomarkers in patients with resected pancreatic adenocarcinoma treated with adjuvant gemcitabine monotherapy?","volume":"11","author":"Jiraskova","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071978","article-title":"MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis","volume":"8","author":"Kadera","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib98","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1097\/SLA.0000000000003945","article-title":"Identification of serum miRNA signature and establishment of a nomogram for risk stratification in patients with pancreatic ductal adenocarcinoma","volume":"275","author":"Kandimalla","year":"2022","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib99","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/carcin\/bgx013","article-title":"MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer","volume":"38","author":"Kanno","year":"2017","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.21873\/cgp.20090","article-title":"Pre-operative plasma miR-21-5p is a sensitive biomarker and independent prognostic factor in patients with pancreatic ductal adenocarcinoma undergoing surgical resection","volume":"15","author":"Karasek","year":"2018","journal-title":"Cancer Genomics Proteomics"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib101","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000494274","article-title":"Expression levels of microRNAs miR-93 and miR-200a in pancreatic adenocarcinoma with special reference to differentiation and relapse-free survival","volume":"96","author":"Karihtala","year":"2019","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jhbp.601","article-title":"Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients","volume":"26","author":"Kawamura","year":"2019","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106528_bib103","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3343\/alm.2025.0121","article-title":"Evaluation of exosome-derived small RNAs as potential biomarkers for pancreatic ductal adenocarcinoma using next-generation sequencing","volume":"45","author":"Kim","year":"2025","journal-title":"Ann Lab Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib104","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s10620-010-1285-3","article-title":"Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis","volume":"56","author":"Kong","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106528_bib105","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1245\/s10434-019-07793-y","article-title":"MiR-194-5p in pancreatic ductal adenocarcinoma peritoneal washings is associated with peritoneal recurrence and overall survival in peritoneal cytology-negative patients","volume":"26","author":"Kubo","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ebiom.2026.106528_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1295936","article-title":"KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients","volume":"13","author":"Lavacchi","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib107","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s12032-013-0700-y","article-title":"Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis","volume":"30","author":"Lee","year":"2013","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib108","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.3390\/ijms15046314","article-title":"GPC1 regulated by miR-96-5p, rather than miR-182-5p, in inhibition of pancreatic carcinoma cell proliferation","volume":"15","author":"Li","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib109","doi-asserted-by":"crossref","first-page":"16372","DOI":"10.4238\/2015.December.9.5","article-title":"Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis","volume":"14","author":"Li","year":"2015","journal-title":"Genet Mol Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib110","first-page":"1418","article-title":"MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma","volume":"19","author":"Li","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ebiom.2026.106528_bib111","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820943237","article-title":"Effect of miR-184 on proliferation and apoptosis of pancreatic ductal adenocarcinoma and its mechanism","volume":"19","author":"Li","year":"2020","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib112","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3892\/ol.2021.12828","article-title":"lncRNA IUR upregulates miR-34a to inhibit pancreatic adenocarcinoma cell migratory and invasive abilities","volume":"22","author":"Li","year":"2021","journal-title":"Oncol Lett"},{"issue":"16","key":"10.1016\/j.ebiom.2026.106528_bib113","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.18632\/oncotarget.3885","article-title":"MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine","volume":"6","author":"Liang","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib114","first-page":"939","article-title":"Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: a study based on The Cancer Genome Atlas and bioinformatics investigation","volume":"17","author":"Liang","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ebiom.2026.106528_bib115","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2147\/CMAR.S168351","article-title":"Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy","volume":"10","author":"Liao","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib116","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1373\/clinchem.2011.172767","article-title":"Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer","volume":"58","author":"Liu","year":"2012","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib117","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tranon.2018.03.003","article-title":"Identification of prognostic biomarkers by combined mRNA and miRNA expression microarray analysis in pancreatic cancer","volume":"11","author":"Liu","year":"2018","journal-title":"Transl Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106528_bib118","first-page":"3384","article-title":"miR-25 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation by targeting ABI2","volume":"19","author":"Lu","year":"2020","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib119","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.4238\/2015.December.23.2","article-title":"Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer","volume":"14","author":"Ma","year":"2015","journal-title":"Genet Mol Res"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib120","first-page":"2705","article-title":"Screening potential microRNAs associated with pancreatic cancer: data mining based on RNA sequencing and microarrays","volume":"20","author":"Ma","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ebiom.2026.106528_bib121","article-title":"Baicalein induces apoptosis of pancreatic cancer cells by regulating the expression of miR-139-3p and miR-196b-5p","volume":"11","author":"Ma","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106528_bib122","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/SLA.0000000000003084","article-title":"Plasma miR-181a-5p downregulation predicts response and improved survival after FOLFIRINOX in pancreatic ductal adenocarcinoma","volume":"271","author":"Meijer","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.ebiom.2026.106528_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/srep42339","article-title":"MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma","volume":"7","author":"Mikamori","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2026.106528_bib124","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fgene.2019.00624","article-title":"Survival analysis of multi-omics data identifies potential prognostic markers of pancreatic ductal adenocarcinoma","volume":"10","author":"Mishra","year":"2019","journal-title":"Front Genet"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106528_bib125","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/bjc.2015.366","article-title":"Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer","volume":"113","author":"Miyamae","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2026.106528_bib126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.omtn.2018.11.019","article-title":"The modulatory role of MicroRNA-873 in the progression of KRAS-driven cancers","volume":"14","author":"Mokhlis","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib127","first-page":"1083","article-title":"Locked nucleic acid in situ hybridization analysis of MicroRNA-21 predicts clinical outcome in patients after resection for pancreatic cancer treated with adjuvant gemcitabine monotherapy","volume":"36","author":"Morinaga","year":"2016","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib128","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/modpathol.2011.142","article-title":"Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma","volume":"25","author":"Nagao","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106528_bib129","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.surg.2011.06.017","article-title":"MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis","volume":"150","author":"Nakata","year":"2011","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106528_bib130","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s11605-016-3208-x","article-title":"MicroRNA expression in a readily accessible common hepatic artery lymph node predicts time to pancreatic cancer recurrence postresection","volume":"20","author":"Nguyen","year":"2016","journal-title":"J Gastrointest Surg"},{"issue":"20","key":"10.1016\/j.ebiom.2026.106528_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70265","article-title":"Exosomal miR-199a-3p secreted from cancer-associated adipocytes promotes pancreatic cancer progression","volume":"13","author":"Noda","year":"2024","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib132","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4161\/cbt.10.8.13083","article-title":"MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion","volume":"10","author":"Yu","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib133","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41467-018-03962-x","article-title":"TGF-beta induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression","volume":"9","author":"Ottaviani","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib134","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.21873\/anticanres.17297","article-title":"Genome-wide microRNA analysis identified miR-210-3p over-expression in pancreatic cancer tissues as a predictor of their local invasiveness","volume":"44","author":"Otsu","year":"2024","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4166\/kjg.2015.66.4.215","article-title":"MicroRNA-200c as a prognostic biomarker for pancreatic cancer","volume":"66","author":"Paik","year":"2015","journal-title":"Korean J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib136","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MPA.0b013e3182592ba7","article-title":"Expression of microRNAs in patients with pancreatic cancer and its prognostic significance","volume":"42","author":"Papaconstantinou","year":"2013","journal-title":"Pancreas"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106528_bib137","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1158\/1078-0432.CCR-11-0695","article-title":"MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma","volume":"17","author":"Preis","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010197","article-title":"Potential of exosomal microRNA-200b as liquid biopsy marker in pancreatic ductal adenocarcinoma","volume":"12","author":"Reese","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106528_bib139","first-page":"465","article-title":"Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA","volume":"3","author":"Sarkar","year":"2013","journal-title":"Am J Cancer Res"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106528_bib140","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.pan.2020.07.399","article-title":"A machine learning approach identified a diagnostic model for pancreatic cancer through using circulating microRNA signatures","volume":"20","author":"Alizadeh Savareh","year":"2020","journal-title":"Pancreatology"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib141","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00268-012-1705-y","article-title":"Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index","volume":"36","author":"Schultz","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.ebiom.2026.106528_bib142","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2147\/OTT.S288936","article-title":"Upregulated MicroRNA-483-3p is an early event in pancreatic ductal adenocarcinoma (PDAC) and as a powerful liquid biopsy biomarker in PDAC","volume":"14","author":"Shao","year":"2021","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib143","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.1038\/s41598-022-13045-z","article-title":"An immune-related microRNA signature prognostic model for pancreatic carcinoma and association with immune microenvironment","volume":"12","author":"Shen","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib144","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.1038\/s41598-018-22493-5","article-title":"A Five-microRNA signature for survival prognosis in pancreatic adenocarcinoma based on TCGA data","volume":"8","author":"Shi","year":"2018","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.ebiom.2026.106528_bib145","first-page":"5187","article-title":"Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer","volume":"22","author":"Shi","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib146","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41416-023-02488-4","article-title":"Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer","volume":"130","author":"Shi","year":"2024","journal-title":"Br J Cancer"},{"issue":"23","key":"10.1016\/j.ebiom.2026.106528_bib147","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.febslet.2014.10.004","article-title":"miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I","volume":"588","author":"Song","year":"2014","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib148","doi-asserted-by":"crossref","first-page":"11319","DOI":"10.1007\/s13277-014-2452-5","article-title":"The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer","volume":"35","author":"Song","year":"2014","journal-title":"Tumour Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib149","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1159\/000373941","article-title":"MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88","volume":"35","author":"Song","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib150","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00432-018-2749-7","article-title":"Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma","volume":"144","author":"Stroese","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"issue":"21","key":"10.1016\/j.ebiom.2026.106528_bib151","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.7150\/jca.27697","article-title":"Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma","volume":"9","author":"Su","year":"2018","journal-title":"J Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib152","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/09674845.2016.1220706","article-title":"Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients","volume":"73","author":"Sun","year":"2016","journal-title":"Br J Biomed Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106528_bib153","first-page":"1491","article-title":"Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins","volume":"52","author":"Sun","year":"2018","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib154","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jhbp.524","article-title":"Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma","volume":"25","author":"Takahasi","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106528_bib155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310328","article-title":"MicroRNA-26a-5p is a reliable biomarker in the adjuvant setting for pancreatic ductal adenocarcinoma","volume":"19","author":"Takeda","year":"2024","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib156","doi-asserted-by":"crossref","DOI":"10.1590\/0102-672020210002e1628","article-title":"Mir-203a-3p and Mmp-2 proteins are highly expressed in circulating tumor cells from patients with pancreatic carcinoma","volume":"34","author":"Tarazona","year":"2022","journal-title":"Arq Bras Cir Dig"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib157","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34597-z","article-title":"Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer","volume":"8","author":"Tavano","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib158","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s00432-018-2755-9","article-title":"The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma","volume":"144","author":"Michael Traeger","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ebiom.2026.106528_bib159","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13000-015-0272-6","article-title":"MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma","volume":"10","author":"Vychytilova-Faltejskova","year":"2015","journal-title":"Diagn Pathol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib160","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.molonc.2012.10.011","article-title":"The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL","volume":"7","author":"Wang","year":"2013","journal-title":"Mol Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib161","doi-asserted-by":"crossref","first-page":"696","DOI":"10.7150\/jca.10094","article-title":"Circulating microRNAs in pancreatic juice as candidate biomarkers of pancreatic cancer","volume":"5","author":"Wang","year":"2014","journal-title":"J Cancer"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib162","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1007\/s13277-015-3690-x","article-title":"Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106528_bib163","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.7150\/jca.110659","article-title":"Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating VEGFA","volume":"16","author":"Wang","year":"2025","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib164","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/JS9.0000000000003449","article-title":"Supervising the recurrence of pancreatic ductal adenocarcinoma using CtDNA-based MIR129-2 methylation detection","volume":"112","author":"Wang","year":"2026","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/CBM-160671","article-title":"Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma","volume":"18","author":"Wu","year":"2017","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.ebiom.2026.106528_bib166","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12935-020-01529-9","article-title":"MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ebiom.2026.106528_bib167","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7752277","article-title":"Hypoxia-induced miR-210 promotes endothelial cell permeability and angiogenesis via exosomes in pancreatic ductal adenocarcinoma","volume":"2022","author":"Wu","year":"2022","journal-title":"Biochem Res Int"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib168","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.yexcr.2017.10.033","article-title":"Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K\/Akt signaling via caveolin-1 and PTEN","volume":"361","author":"Xiong","year":"2017","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib169","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2022.2148433","article-title":"A key regulatory loop AK4P1\/miR-375\/SP1 in pancreatic adenocarcinoma","volume":"18","author":"Xu","year":"2023","journal-title":"Epigenetics"},{"key":"10.1016\/j.ebiom.2026.106528_bib170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fbioe.2020.00379","article-title":"The serum MicroRNA signatures for pancreatic cancer detection and operability evaluation","volume":"8","author":"Yan","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106528_bib171","first-page":"8801","article-title":"Hsa-miR-4730 as a new and potential diagnostic and prognostic indicators for pancreatic cancer","volume":"24","author":"Yang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ebiom.2026.106528_bib172","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2782101","article-title":"MicroRNA-7 as a potential biomarker for prognosis in pancreatic cancer","volume":"2020","author":"Ye","year":"2020","journal-title":"Dis Markers"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106528_bib173","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.7150\/jca.18931","article-title":"MicroRNA-216b-5p functions as a tumor-suppressive RNA by targeting TPT1 in pancreatic cancer cells","volume":"8","author":"You","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.ebiom.2026.106528_bib174","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1476-4598-9-169","article-title":"MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation","volume":"9","author":"Yu","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ebiom.2026.106528_bib175","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6495867","article-title":"Evaluation of plasma MicroRNAs as diagnostic and prognostic biomarkers in pancreatic adenocarcinoma: miR-196a and miR-210 could be negative and positive prognostic markers, respectively","volume":"2017","author":"Yu","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ebiom.2026.106528_bib176","first-page":"497","article-title":"Down-regulation of MiR-539 indicates poor prognosis in patients with pancreatic cancer","volume":"13","author":"Yu","year":"2018","journal-title":"Open Life Sci"},{"key":"10.1016\/j.ebiom.2026.106528_bib177","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2147\/CMAR.S158712","article-title":"A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma","volume":"10","author":"Yu","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106528_bib178","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1002\/cam4.3559","article-title":"Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival","volume":"9","author":"Yuan","year":"2020","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib179","first-page":"2359","article-title":"miR-212 regulated by HIF-1alpha promotes the progression of pancreatic cancer","volume":"17","author":"Yue","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ebiom.2026.106528_bib180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1746-1596-9-61","article-title":"Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients","volume":"9","author":"Zhang","year":"2014","journal-title":"Diagn Pathol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib181","article-title":"miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2026.106528_bib182","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.1007\/s13277-016-5445-8","article-title":"MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1","volume":"37","author":"Zhao","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ebiom.2026.106528_bib183","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.gene.2018.06.037","article-title":"Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: a miRNA expression analysis","volume":"673","author":"Zhou","year":"2018","journal-title":"Gene"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106528_bib184","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-013-1897-y","article-title":"Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma","volume":"388","author":"Zhu","year":"2014","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jso.23475","article-title":"Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival","volume":"109","author":"Zhu","year":"2014","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106528_bib186","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bbrc.2018.02.005","article-title":"MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma","volume":"497","author":"Zhu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib187","first-page":"843","article-title":"miR-205 targets runt-related transcription factor 2 to inhibit human pancreatic cancer progression","volume":"17","author":"Zhuang","year":"2019","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106528_bib188","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1002\/cam4.2145","article-title":"Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis","volume":"8","author":"Zou","year":"2019","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071309","article-title":"MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells","volume":"8","author":"Su","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2026.106528_bib190","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/386561","article-title":"Aberrant MicroRNAs in pancreatic cancer: researches and clinical implications","volume":"2014","author":"Sun","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ebiom.2026.106528_bib191","article-title":"miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial-mesenchymal transition and the Notch signaling pathway","volume":"7","author":"Tang","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib192","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1503\/cmaj.060410","article-title":"The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey","volume":"176","author":"Ioannidis","year":"2007","journal-title":"CMAJ"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106528_bib193","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41591-021-01458-8","article-title":"Accelerating the translational medicine cycle: the Academia Europaea pilot","volume":"27","author":"Hegyi","year":"2021","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106528_bib194","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1038\/s41591-025-03992-1","article-title":"Academia Europaea's guidelines for the visualization of clinical outcomes","volume":"31","author":"Hegyi","year":"2025","journal-title":"Nat Med"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106528_bib195","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.18632\/oncotarget.28038","article-title":"The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis","volume":"12","author":"Vieira","year":"2021","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106528_bib196","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3892\/ol.2020.11691","article-title":"Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer","volume":"20","author":"Wu","year":"2020","journal-title":"Oncol Lett"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106528_bib197","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110948","article-title":"The multifaceted role of miR-21 in pancreatic cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106528_bib198","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","article-title":"The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106528_bib199","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031275","article-title":"microRNA-21 regulates stemness in pancreatic ductal adenocarcinoma cells","volume":"23","author":"Mortoglou","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426004123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426004123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:50:02Z","timestamp":1793616602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426004123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":199,"alternative-id":["S2352396426004123"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106528","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106528"}}